{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:58:09Z","timestamp":1786651089464,"version":"build-2736575974"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/1008-682x.126382","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T07:05:27Z","timestamp":1400051127000},"page":"767","source":"Crossref","is-referenced-by-count":13,"title":["Clinical correlates of enlarged prostate size in subjects with sexual dysfunction"],"prefix":"10.4103","volume":"16","author":[{"given":"Mario","family":"Maggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Maseroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rastrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vignozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.126382-1","first-page":"475","volume-title":"Chronic inflammation in the pathogenesis of benign prostatic hyperplasia","author":"Fibbi","year":"2010","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.126382-2","first-page":"606","volume-title":"Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis","author":"Kirby","year":"2013","journal-title":"Int J Clin Pract"},{"key":"key-10.4103\/1008-682X.126382-3","first-page":"118","volume-title":"EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-4","first-page":"809","volume-title":"Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia","author":"Gacci","year":"2011","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-5","first-page":"3418","volume-title":"Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-6","first-page":"292","volume-title":"Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism (s) of action","author":"Andersson","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"key-10.4103\/1008-682X.126382-7","first-page":"337","volume-title":"Recommendations for the clinical evaluation of men and women with sexual dysfunction","author":"Hatzichristou","year":"2010","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-8","first-page":"108","volume-title":"SOP: physical examination and laboratory testing for men with erectile dysfunction","author":"Ghanem","year":"2013","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-9","first-page":"2518","volume-title":"Serum PSA as a predictor of testosterone deficiency","author":"Rastrelli","year":"2013","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-10","first-page":"285","volume-title":"Erectile and ejaculatory problems in gay and heterosexual men","author":"Bancroft","year":"2005","journal-title":"Arch Sex Behav"},{"key":"key-10.4103\/1008-682X.126382-11","first-page":"581","volume-title":"Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.126382-12","first-page":"1645","volume-title":"Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study","author":"Bohnen","year":"2007","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-13","first-page":"742","volume-title":"Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study","author":"Chung","year":"2006","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.126382-14","first-page":"695","volume-title":"Prostate specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia","author":"Mochtar","year":"2003","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-15","first-page":"26","volume-title":"Standard Operating Procedures for Taking a Sexual History","author":"Althof","year":"2013","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-16","first-page":"210","volume-title":"Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction","author":"Petrone","year":"2003","journal-title":"Int J Impot Res"},{"key":"key-10.4103\/1008-682X.126382-17","first-page":"795","volume-title":"Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction","author":"Corona","year":"2006","journal-title":"J Androl"},{"key":"key-10.4103\/1008-682X.126382-18","first-page":"3126","volume-title":"It Takes Two to Tango\": the Relational Domain in a Cohort of Subjects with Erectile Dysfunction (ED)","author":"Boddi","year":"2012","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-19","first-page":"2591","volume-title":"Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism","author":"Corona","year":"2009","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-20","first-page":"2017","volume-title":"SIEDY Scale 3, a New Instrument to Detect Psychological Component in Subjects with Erectile Dysfunction","author":"Corona","year":"2012","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-21","first-page":"86","volume-title":"Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions","author":"Corona","year":"2006","journal-title":"J Androl"},{"key":"key-10.4103\/1008-682X.126382-22","first-page":"1074","volume-title":"Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction","author":"Corona","year":"2013","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-23","first-page":"508","volume-title":"The hormonal control of ejaculation","author":"Corona","year":"2012","journal-title":"Nat Rev Urol"},{"key":"key-10.4103\/1008-682X.126382-24","first-page":"41","volume-title":"Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu","author":"Corona","year":"2011","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.126382-25","first-page":"453","volume-title":"Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions","author":"Corona","year":"2006","journal-title":"J Androl"},{"key":"key-10.4103\/1008-682X.126382-26","doi-asserted-by":"crossref","unstructured":"Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 1966; 112: 917-23.","DOI":"10.1192\/bjp.112.490.917"},{"key":"key-10.4103\/1008-682X.126382-27","first-page":"720","volume-title":"The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction","author":"Corona","year":"2009","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.126382-28","first-page":"458","volume-title":"Association between psychiatric symptoms and erectile dysfunction","author":"Corona","year":"2007","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-29","first-page":"483","volume-title":"Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms","author":"McGregor","year":"2005","journal-title":"Am J Epidemiol"},{"key":"key-10.4103\/1008-682X.126382-30","first-page":"469","volume-title":"Metabolic syndrome--a new world-wide definition.A Consensus Statement from the International Diabetes Federation","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"key-10.4103\/1008-682X.126382-31","first-page":"2623","volume-title":"Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease","author":"Corona","year":"2008","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-32","first-page":"120","volume-title":"Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound","author":"Sikka","year":"2013","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-33","unstructured":"Hatzichristou D, Rosen R, Derogatis L, Low WY, Meuleman E, et al. Clinical evaluation and symptom scales in men and women with sexual dysfunction. In: Montorsi, Basson Adaikan, Becher, Clayton, Giuliano, et al. editors. Sexual Medicine: sexual dysfunctions in men and women. The 3 rd International Consultation on Sexual Medicine. Health Publication Ltd: Paris, France; 2010. p. 229-80."},{"key":"key-10.4103\/1008-682X.126382-34","first-page":"173","volume-title":"Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors","author":"Rastrelli","year":"2014","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-35","first-page":"600","volume-title":"Ultrasonographic and clinical correlates of seminal plasma interleukin-8 levels in patients attending an andrology clinic for infertility","author":"Lotti","year":"2011","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.126382-36","first-page":"61","volume-title":", EAU guidelines on prostate cancer.Part 1: screening, diagnosis, and treatment of clinically localised disease","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-37","doi-asserted-by":"crossref","unstructured":"Corona G, Vignozzi L, Rastrelli G, Lotti F, Cipriani S, et al. Benign prostatic hyperplasia a new metabolic disease of the aging male. Int J Endocrinology 2014.","DOI":"10.1155\/2014\/329456"},{"key":"key-10.4103\/1008-682X.126382-38","first-page":"71","volume-title":"Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit","author":"Vignozzi","year":"2012","journal-title":"J Endocrinol"},{"key":"key-10.4103\/1008-682X.126382-39","first-page":"101","volume-title":"Metabolic syndrome and lower urinary tract symptoms: the role of inflammation","author":"Gacci","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key-10.4103\/1008-682X.126382-40","first-page":"313","volume-title":"Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men","author":"Parsons","year":"2008","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.126382-41","first-page":"387","volume-title":"Correlation of benign prostatic hyperplasia with hyperlipemia","author":"Li","year":"2005","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"key-10.4103\/1008-682X.126382-42","first-page":"789","volume-title":"Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation","author":"Vignozzi","year":"2013","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.126382-43","first-page":"10","volume-title":"The dark side of testosterone deficiency: I.Metabolic syndrome and erectile dysfunction","author":"Traish","year":"2009","journal-title":"J Androl"},{"key":"key-10.4103\/1008-682X.126382-44","unstructured":"Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E, et al. Hypogonadism and Metabolic Syndrome. J Endocrinol Invest 2011; 34: 557-67"},{"key":"key-10.4103\/1008-682X.126382-45","first-page":"222","volume-title":"Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study","author":"Kupelian","year":"2006","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.126382-46","first-page":"637","volume-title":"Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-47","first-page":"1073","volume-title":"Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction","author":"Berger","year":"2005","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.126382-48","first-page":"1038","volume-title":"Atherosclerosis as a risk factor for benign prostatic hyperplasia","author":"Berger","year":"2006","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.126382-49","first-page":"470","volume-title":"Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: Assessment using colour Doppler ultrasonography","author":"Pinggera","year":"2008","journal-title":"BJU Int"},{"key":"key-10.4103\/1008-682X.126382-50","first-page":"249","volume-title":"Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study","author":"Park","year":"2013","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.126382-51","first-page":"285","volume-title":"Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED","author":"Corona","year":"2009","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-52","first-page":"2878","volume-title":"The association between varicocele, premature ejaculation and prostatitis symptoms: possible mechanisms","author":"Lotti","year":"2009","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-53","first-page":"273","volume-title":"Reversal of benign prostate hyperplasia by selective occlusion of impaired venous drainage in the male reproductive system: Novel mechanism, new treatment","author":"Gat","year":"2008","journal-title":"Andrologia"},{"key":"key-10.4103\/1008-682X.126382-54","first-page":"198","volume-title":"Prevalence of chronic prostatitis in men with premature ejaculation","author":"Screponi","year":"2001","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.126382-55","first-page":"668","volume-title":"Thyroid hormones and male sexual function","author":"Corona","year":"2012","journal-title":"Int J Androl"},{"key":"key-10.4103\/1008-682X.126382-56","doi-asserted-by":"crossref","unstructured":"Carani C, Isidori AM, Granata A, Carosa E, Maggi M, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 2005; 90: 6472-9","DOI":"10.1210\/jc.2005-1135"},{"key":"key-10.4103\/1008-682X.126382-57","first-page":"1391","volume-title":"PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS","author":"Vignozzi","year":"2013","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.126382-58","first-page":"428","volume-title":"Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit","author":"Morelli","year":"2013","journal-title":"Prostate"},{"key":"key-10.4103\/1008-682X.126382-59","first-page":"2135","volume-title":"The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation","author":"Jannini","year":"2011","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-60","first-page":"328","volume-title":"Evaluation of premature ejaculation","author":"Jannini","year":"2011","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-61","first-page":"803","volume-title":"Quality of life and erectile dysfunction","author":"Althof","year":"2002","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.126382-62","first-page":"240","volume-title":"Symptomatic benign prostate hyperplasia: impact on partner\u2032s quality of life","author":"Mitropoulos","year":"2002","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-63","first-page":"690","volume-title":"Use of a prostate model to assist in training for digital rectal examination.Urology","author":"Yanoshak","year":"2000","journal-title":""},{"key":"key-10.4103\/1008-682X.126382-64","first-page":"1087","volume-title":"Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination","author":"Roehrborn","year":"2001","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.126382-65","first-page":"994","volume-title":"A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1- blockers for lower uninary tract symtoms due to benign prostatic hyperplasia","author":"Gacci","year":"2012","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.126382-66","first-page":"2746","volume-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","author":"Morelli","year":"2011","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.126382-67","first-page":"107","volume-title":"Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats","author":"Morelli","year":"2010","journal-title":"J Sex Med"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:26:34Z","timestamp":1786649194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1008-682X.126382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"alternative-id":["126382"],"URL":"https:\/\/doi.org\/10.4103\/1008-682x.126382","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}